Drugs / PMG1016
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07615985 | May → Nov 2026 expected | chronic kidney disease | Pulmongene Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PMG1016 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07615985 ↗ |
| Route | Intravenous | “PMG1016 administered via IV infusion” NCT07615985 ↗ |